Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Celgene Corp. buy matumba

Celgene Corp.
Start price
€24.05
22.10.11 / 50%
Target price
€26.08
28.12.11
Performance (%)
8.41%
End price
€26.08
28.12.11
Summary
This prediction ended on 28.12.11 with a price of €26.08. The BUY prediction by matumba finished with a performance of 8.41%. matumba has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Celgene Corp. - - - -
iShares Core DAX® 1.732% 4.638% 21.634% 71.886%
iShares Nasdaq 100 3.304% 0.517% 5.422% 113.046%
iShares Nikkei 225® 2.342% 0.972% 15.333% 47.267%
iShares S&P 500 2.357% 0.872% 3.125% 68.687%

Comments by matumba for this prediction

In the thread Celgene Corp. diskutieren
Prediction Buy
Perf. (%) 8.41%
Target price 26.075
Change
Ends at 28.12.11

risikobereit?

Revlimid Präparat gegen Krebs soll 2012 ein Umsatzplus von 30% bringen (3,15MRD Dollar)

Europ. Arzneimittelagentur hat sich positiv geäußert- dies ermögl. gute Chancen

 

matumba 
0
Report Share
22.10.11
Prediction Buy
Perf. (%) 8.41%
Target price 26.075
Change
Ends at 28.12.11

(Zielkurs erreicht)

matumba 
0
Report Share
28.12.11

Stopped prediction by matumba for Celgene Corp.

buy
Celgene Corp.

Start price
Target price
Perf. (%)
€27.34
23.05.12
€29.75
20.09.12
9.09%
20.09.12

matumba 
24.08.19 50%